Vaughan Clift - Ampio Pharmaceuticals Insider

AMPE -- USA Stock  

USD 0.52  0.0191  3.52%

  Executive
Dr. Vaughan Lennox Clift, M.D., serves as Chief Regulatory Affairs Officer of Ampio Pharmaceuticals, Inc. Dr. Clift was employed as Ampios Chief Regulatory Affairs Officer from March 2010 until July 2016 and was employed by Life Sciences from May 2009 until March 2010. From 2005 to 2009, Dr. Clift was the chief executive officer of Detectachem LLC, a Houston, Texasbased manufacturer of a handheld explosive and narcotics detection device. Dr. Clift was the Vice President of Operations for Isolagen from 2002 until 2005.
Age: 54        
720-437-6500  http://www.ampiopharma.com

Management Efficiency

The company has return on total asset (ROA) of (73.61) % which means that it has lost $73.61 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (253.19) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Showing few of many executives

EXECUTIVE Since

Thomas JungAuris Medical Holding AG
2016
Anne ZollerAuris Medical Holding AG
2015
Oliver KubliAuris Medical Holding AG
2010
Andrea BraunAuris Medical Holding AG
2016
Carole HoDenali Therapeutics
2015
Herbert DOEdge Therapeutics
N/A
Ralf RosskampDicerna Pharmaceuticals
2017
Lee AllenDova Pharmaceuticals
2017
Wolfgang ArnoldAuris Medical Holding AG
2007
Bettina StubinskiAuris Medical Holding AG
2013
Albert IIEdge Therapeutics
N/A
Alison ArmourEndocyte
2015
Pankaj BhargavaDicerna Pharmaceuticals
2014
Cindy McGeeAuris Medical Holding AG
2016
Beth TaylorEndocyte
2016
Albert MarchioEdge Therapeutics
2017
Herbert FaleckEdge Therapeutics
2013
James WeissmanDicerna Pharmaceuticals
2012
Gregory GinEdge Therapeutics
2018
Sonja NelsonNantKwest
2018

Entity Summary

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado. Ampio Pharmaceuticals operates under Biotechnology classification in USA and traded on BATS Exchange. It employs 17 people.Ampio Pharmaceuticals (AMPE) is traded on BATS Exchange in USA. It is located in COLORADO U.S.A and employs 17 people. Ampio Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.

Ampio Pharmaceuticals Leadership Team

Thomas Chilcott, Interim CFO
Vaughan Clift, Chief Regulatory Affairs Officer
Holli Cherevka, COO
David Stevens, Independent Director
Philip Coelho, Director, Chairman of Compensation Committee, Chairman of Nominating and Governance Committee and Member of Audit Committee
Richard Giles, Director of Investor Relations, Director, Chairman of Audit Committee, Member of Nominating and Governance Committee and Member of Compensation Committee
Gregory Gould, CFO, Treasurer, Corporate Secretary
David BarOr, Chief Scientific Officer, Director
Michael MacAluso, Founder, Chairman and CEO

Stock Performance Indicators

Shares Outstanding106.54 M
window.location = "/error404.html";
Search macroaxis.com